2004
DOI: 10.1373/clinchem.2004.031286
|View full text |Cite
|
Sign up to set email alerts
|

Measurement of Nε-(Carboxymethyl)lysine and Nε-(Carboxyethyl)lysine in Human Plasma Protein by Stable-Isotope-Dilution Tandem Mass Spectrometry

Abstract: Results: CML and CEL were separated with baseline resolution with a total analysis time of 21 min. The lower limit of quantification was 0.02 mol/L for both compounds. Mean recoveries from plasma samples to which CML and CEL had been added were 92% for CML and 98% for CEL. Within-day CVs were <7.2% for CML and <8.2% for CEL, and between-day CVs were <8.5% for CML and <9.0% for CEL. In healthy individuals (n ‫؍‬ 10), mean (SD) plasma concentrations of CML and CEL were 2.80 (0.40) mol/L (range, 2.1-3.4 mol/L) an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
104
0

Year Published

2006
2006
2021
2021

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 117 publications
(108 citation statements)
references
References 24 publications
4
104
0
Order By: Relevance
“…In 3T3‐L1 cells treated with CML starting at differentiation, we observed an increase in lipid accumulation to similar extent after treatment with 5, 50, or 500 μM CML. This demonstrates CML to influence lipid accumulation also in plasma relevant concentrations, as plasma concentrations of healthy individuals centre around 2.8 μM [Teerlink et al, 2004], reaching around 12 μM in diabetic subjects with compromised renal function [Lieuw et al, 2004]. Furthermore, trapping of CML in adipose tissue has been reported [Jia et al, 2012], which may yield in even higher local concentrations.…”
Section: Discussionmentioning
confidence: 99%
“…In 3T3‐L1 cells treated with CML starting at differentiation, we observed an increase in lipid accumulation to similar extent after treatment with 5, 50, or 500 μM CML. This demonstrates CML to influence lipid accumulation also in plasma relevant concentrations, as plasma concentrations of healthy individuals centre around 2.8 μM [Teerlink et al, 2004], reaching around 12 μM in diabetic subjects with compromised renal function [Lieuw et al, 2004]. Furthermore, trapping of CML in adipose tissue has been reported [Jia et al, 2012], which may yield in even higher local concentrations.…”
Section: Discussionmentioning
confidence: 99%
“…Unbound CML and CEL were measured in EDTA plasma by high-performance liquid chromatography with stable isotope dilution tandem mass spectrometric detection using a procedure developed for the analysis of protein-bound CML and CEL (22), with a modified sample preparation procedure. Briefly, after centrifugation of the plasma samples (5 min at 20,000g), 50 l of the supernatant was mixed with 150 l of a combined internal standard solution (containing deuterated CML and CEL), and proteins were removed by centrifugation (20 min at 15,000g) in a 10-kDa cutoff ultrafiltration device (Vivaspin 500 PES; Vivascience, Hannover, Germany).…”
Section: Laboratory Analysismentioning
confidence: 99%
“…Briefly, after centrifugation of the plasma samples (5 min at 20,000g), 50 l of the supernatant was mixed with 150 l of a combined internal standard solution (containing deuterated CML and CEL), and proteins were removed by centrifugation (20 min at 15,000g) in a 10-kDa cutoff ultrafiltration device (Vivaspin 500 PES; Vivascience, Hannover, Germany). A 90-l aliquot of the ultrafiltrate was mixed with 10 l of a 50 mmol/l nonafluoropentanoic acid solution, and 25 l of this mixture was subjected to liquid chromatography tandem mass spectrometry analysis, as described before (22). Intra-assay and interassay CVs for CML were 3 and 4%, respectively, and for CEL, 5 and 9%, respectively.…”
Section: Laboratory Analysismentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, to assess the degree of glycation at a given pathophysiological condition, precise identification of glycation becomes critical. In this regard, a stable-isotope-dilution tandem mass spectrometry method was employed for simultaneous analysis of CML and CEL in hydrolysates of plasma proteins (28), and 13 C6-glucose was utilized to quantify glycated proteins in the plasma and erythrocytes (29,30). In a recent study, the glycationsensitive peptides of HSA that could serve as markers for early diagnosis of type 2 diabetes were quantified by using an MS-based 18 O-labeling technique (31).…”
mentioning
confidence: 99%